Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthetic route for HCV NS5A inhibitor intermediate offering cost reduction and scalable manufacturing for pharmaceutical supply chains globally.
Patent CN104592118A reveals a novel solvent-free synthesis for saturated imidazolinium salts, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN115572317B reveals optimized esterification. Delivers high-purity pharmaceutical intermediates with reduced purification burden for supply chain stability.
Patent CN108047093A details a novel Suzuki coupling route for Sacubitril intermediates. This method ensures high chiral purity and significant cost reduction for scalable pharmaceutical manufacturing.
Novel patent CN120441449A reveals efficient Tobuterol intermediate synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN112794849B details a novel, eco-friendly route to 3-(2-chloroethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, eliminating toxic POCl3 and enhancing supply chain stability.
Patent CN1288133C reveals a 4-step route to Levetiracetam, significantly improving yield and safety over traditional 6-step methods for reliable API supply.
Novel dehydration-epoxidation route for Delta9,11-canrenone achieves >80% yield. Reduces steps vs fermentation. Ideal for eplerenone manufacturing.
Novel green synthesis of risperidone intermediate avoiding POCl3. High yield, scalable process for reliable pharmaceutical intermediate supply.
Patent CN110092746B reveals a green, high-yield route for 2-amino-5-halopyridines using 4-cyano-1-butyne, offering significant cost reduction and supply chain stability for API manufacturing.
Patent CN109776381B details a green aqueous synthesis for spiro indolones using quaternary ammonium iodide, offering significant cost reduction and supply chain reliability.
Patent CN112110951A reveals a novel aqueous-phase radical coupling method for Bryostatin C-ring precursors, offering significant cost reduction in fine chemical manufacturing and enhanced supply chain reliability.
Novel nickel-catalyzed route offers high-purity dibenzocycloheptane intermediates with streamlined scalability and reduced environmental impact for global supply chains.
Discover the novel sulfuric acid hydrolysis route for DL-pantolactone in patent CN114773295A. Achieve high purity Vitamin B5 intermediates with reduced wastewater and solvent-free extraction.
Patent CN111087315A reveals a novel aqueous hydrogenation route for Eltrombopag intermediate BPCA, offering superior purity and reduced manufacturing costs for pharmaceutical supply chains.
Patent CN108997193B reveals a cobalt-catalyzed C-H activation method for difluoroalkyl heterocycles, offering cost-effective synthesis for pharma and agrochemical applications.
Patent CN111909089B reveals a high-speed counter-current chromatography method for purifying 950U77, offering superior yield and purity for pharmaceutical quality control.
Patent CN109988090B reveals a green Rh-catalyzed route for tetrahydropyrroles. Offers high diastereoselectivity and mild conditions for pharma intermediates.
Novel Ru-catalyzed route for (S)-duloxetine intermediate offers high ee and yield without nitrogen protection, reducing manufacturing costs.
Patent CN112341417A details a novel light/copper co-catalyzed route for polysubstituted furans, offering mild conditions and enhanced supply chain reliability for pharmaceutical intermediates.